About Park Avenue Dermatology
Clinical Trials at Park Avenue Dermatology
During the past decade, Park Avenue Dermatology conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 27 clinical trials were completed, i.e. on
average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 19 clinical trials were completed. i.e. 190%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Park Avenue Dermatology" #1 sponsor was "Pfizer" with 17 trials, followed by "Eli Lilly and Company" with 6 trials
sponsored, "Peplin" with 6 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored and "LEO Pharma"
with 4 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Park Avenue Dermatology"
#1 collaborator was "Dermira, Inc." with 2 trials as a collaborator, "Basilea Pharmaceutica" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator and "TKL Research, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Park Avenue Dermatology
According to Clinical.Site data, the most researched conditions in "Park Avenue Dermatology" are
"Psoriasis" (11 trials), "Actinic Keratosis" (6 trials), "Atopic Dermatitis" (6 trials), "Alopecia Areata" (4 trials) and "Plaque Psoriasis" (4 trials). Many other conditions were trialed in "Park Avenue Dermatology" in a lesser frequency.
Clinical Trials Intervention Types at Park Avenue Dermatology
Most popular intervention types in "Park Avenue Dermatology" are "Drug" (44 trials), "Other" (4 trials), "Biological" (3 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (18 trials), "PF-06700841" (4 trials), "Guselkumab" (3 trials), "PF-06651600" (3 trials) and "CP-690,550" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Park Avenue Dermatology
The vast majority of trials in "Park Avenue Dermatology" are
46 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Park Avenue Dermatology
Currently, there are NaN active trials in "Park Avenue Dermatology".
undefined are not yet recruiting,
4 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 32 completed trials in Park Avenue Dermatology,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Park Avenue Dermatology, 1 "Phase 1"
clinical trials were conducted, 21 "Phase 2" clinical
trials and 23 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".